NXL103 (formerly XRP 2868) is an experimental drug candidate under development by Novexel. It is an oral streptogramin antibiotic that has potent in vitro activity against certain Gram positive bacteria including methicillin resistant Staphylococcus aureus (MRSA) as well as the important respiratory pathogens including penicillin-, macrolide- and quinolone-resistant strains. It is a combination of linopristin and flopristin.
Positive results have been reported from a phase II trial comparing it with amoxicillin. Another phase II trial will be run in 2010 comparing it with linezolid for treatment of acute bacterial skin and skin structure infections (ABSSSI).
Ripple is a real-time gross settlement system (RTGS), currency exchange and remittance network by Ripple. Also called the Ripple Transaction Protocol (RTXP) or Ripple protocol, it is built upon a distributed open source Internet protocol, consensus ledger and native currency called XRP (ripples). Released in 2012, Ripple purports to enable "secure, instant and nearly free global financial transactions of any size with no chargebacks." It supports tokens representing fiat currency, cryptocurrency, commodity or any other unit of value such as frequent flier miles or mobile minutes. At its core, Ripple is based around a shared, public database or ledger, which uses a consensus process that allows for payments, exchanges and remittance in a distributed process. The security of the Ripple consensus algorithm was challenged by rivals in 2014, with Ripple defending the safety of the system.As of 2016, Ripple is the second-largest cryptocurrency by market capitalization, after bitcoin. Currently implemented by companies such as Fidor Bank, the Ripple protocol has been increasingly adopted by banks and payment networks as settlement infrastructure technology, with American Banker explaining that "from banks' perspective, distributed ledgers like the Ripple system have a number of advantages over cryptocurrencies like bitcoin," including price and security.
Get up on this baby, If you want me, than take me away. (yeah)
Every time I look into your eyes (your eyes)
It brings me back to those times, when you and I, had our time.
It didnt mean too much to me, weather you stayed or you leave, boy I just need to be thugged down.
You know what I like baby. You know what it do, so fellas grab your ladies, and ladies grab your boo.
Want you to know what you do to me, I cant stay away from you, baby Ive tried my hardest, Its just something I cant do.
So get up on this baby, If you want me, than take me
..away.
Sometimes if youre lonely, do I cross your mind?
Boy youve got to show me, if Im what you want in life.
You know you cant replace me, how could you try to play me?Than turn around and blame me?(nox6)
About to show you how I feel inside, all of the pain and the tears that Ive cried, so many times youve lied, so many lonely nights.
Atleast I know I can say I tried, tried to keep our love alive, and boy you cant deny
.theres something in your eyes.
So get up on this baby, If you want me, than take me away.
NXL103 (formerly XRP 2868) is an experimental drug candidate under development by Novexel. It is an oral streptogramin antibiotic that has potent in vitro activity against certain Gram positive bacteria including methicillin resistant Staphylococcus aureus (MRSA) as well as the important respiratory pathogens including penicillin-, macrolide- and quinolone-resistant strains. It is a combination of linopristin and flopristin.
Positive results have been reported from a phase II trial comparing it with amoxicillin. Another phase II trial will be run in 2010 comparing it with linezolid for treatment of acute bacterial skin and skin structure infections (ABSSSI).